AI & ChatGPT searches , social queriess for DANIEL MRZ
Search references for DANIEL MRZ. Phrases containing DANIEL MRZ
See searches and references containing DANIEL MRZ!
Search references for DANIEL MRZ. Phrases containing DANIEL MRZ
See searches and references containing DANIEL MRZ!DANIEL MRZ
blood. Those that are in CNS but not in blood suggest a diagnosis of MS. MRZ-Reaction: A polyspecific antiviral immune response against the viruses of
Biomarkers of multiple sclerosis
Biomarkers_of_multiple_sclerosis
Pharmaceutical compound
been described. The drug was described in the scientific literature by Daniel Trachsel in 2002. It is not a controlled substance in Canada as of 2025
Isobuscaline
Pharmaceutical compound
of 18 to 24 hours. DOTMA was described in the scientific literature by Daniel Trachsel in 2013. The 6-methyl-DOM analogue of DOTMA and Ganesha, Juno,
DOTMA
Class of chemical compounds
literature reviews. They have also been studied by David E. Nichols and Daniel Trachsel, among other researchers. A closely related group is thioscalines
Scaline
Pharmaceutical compound
amphetamine (α-methyl) derivative of fluoroproscaline (FP). According to Daniel Trachsel, 3C-FP's dose is 25 mg or more orally and its duration is approximately
3C-FP
Class of chemical compounds
drugs. 4C drugs have been developed and/or studied by Alexander Shulgin, Daniel Trachsel, and Michael Cunningham and colleagues. Various other 4C drugs
4C_(psychedelics)
Drug mixture used mainly to treat ADHD and narcolepsy
exercise reduces withdrawal symptoms and relapse in abstinent smokers (Daniel et al., 2006; Prochaska et al., 2008), and one drug recovery program has
Adderall
British short-range jet airliner (1963–2019)
Museo Nacional Aeronáutico y del Espacio in Santiago, Chile. One-Eleven LV-MRZ in San Justo Shopping, Buenos Aires, Argentina with DC-9 tail One-Eleven
BAC_One-Eleven
Pharmaceutical compound
Nichols and colleagues at Purdue University and was subsequently reported by Daniel Trachsel in 2013, who obtained the information via personal communication
Bromojimscaline
Class of chemical compounds
MEM). 3C drugs have been developed and/or studied by Alexander Shulgin and Daniel Trachsel, among others. The pharmacology of 3C drugs has been studied and
3C_(psychedelics)
Pharmaceutical compound
(Fen-Phen). The compound was first described in the scientific literature by Daniel Trachsel in his book on phenethylamines in 2013. It is not known to have
Phenflutermine
Class of depressant drugs derived from barbituric acid
Agents". Archived from the original on 7 June 2008. Retrieved 15 July 2008. Daniel Engber (3 May 2006). "Why do lethal injections have three drugs?". Slate
Barbiturate
Colorless gas with the formula NO
2174/138161280506230110111042. PMID 10390607. Culotta, Elizabeth; Koshland, Daniel E. Jr. (1992). "NO news is good news". Science. 258 (5090): 1862–1864. Bibcode:1992Sci
Nitric_oxide
Pharmaceutical compound
in humans. 2C-BI-8 was first described in the scientific literature by Daniel Trachsel and David E. Nichols and colleagues in 2009. It is a controlled
2C-BI-8
Colourless non-flammable greenhouse gas
System Research Laboratories. Retrieved 15 February 2021. Ravishankara AR, Daniel JS, Portmann RW (27 August 2009), "Nitrous Oxide (N2O): The Dominant Ozone-Depleting
Nitrous_oxide
Pharmaceutical compound
drug has been encountered online as a novel designer drug. According to Daniel Trachsel in 2012, who cited personal communication with P. Rausch in 2009
2,4,6-Trimethoxyphenethylamine
2,4,6-Trimethoxyphenethylamine
CNS stimulant and isomer of amphetamine
exercise reduces withdrawal symptoms and relapse in abstinent smokers (Daniel et al., 2006; Prochaska et al., 2008), and one drug recovery program has
Dextroamphetamine
Chemical compound
been described. 3C-MAL was first described in the scientific literature by Daniel Trachsel in 2002. It is a controlled substance in Canada under Amphetamine
3C-MAL
Pharmaceutical compound
Trifluoroproscaline was first described in the scientific literature by Daniel Trachsel in 2012. Its pharmacology was subsequently studied in greater detail
Trifluoroproscaline
Pharmaceutical compound
Nichols and colleagues at Purdue University and was subsequently reported by Daniel Trachsel in 2013, who obtained the information via personal communication
Bromotomscaline
parliament demand". twitter.com. 2 December 2022. "Landtagsprotokoll vom 2. Mrz 2023 - Abänderung des Allgemeinen Bürgerlichen Gesetzbuches und des Partnerschaftsgesetzes
Same-sex marriage in Liechtenstein
Same-sex_marriage_in_Liechtenstein
Chemical compound
of the 3,4-methylenedioxy ring have been replaced with fluorine atoms. Daniel Trachsel tested DFMDA in humans and found that it was inactive at doses
DFMDA
Class of chemical compounds
β-hydroxy-2C-B) and 3C-BOH (β-methoxy-MDA; BOMDA) were later described by Daniel Trachsel in 2013. In addition, BOHB emerged as a novel designer drug. On
BOx_(psychedelics)
Category of Indian nationality law
holder The information page ends with the Machine Readable Passport Zone (MRZ). The OCI certificate contains a note: This is to certify that the person
Overseas_Citizenship_of_India
Central nervous system stimulant
exercise reduces withdrawal symptoms and relapse in abstinent smokers (Daniel et al., 2006; Prochaska et al., 2008), and one drug recovery program has
Methamphetamine
Pharmaceutical compound
in comparison. 2-Bromo-TMA was described in the scientific literature by Daniel Trachsel and colleagues in 2013, who cited personal communication with P
2-Bromo-TMA
Chemical compound
in animal studies. It was first discussed as a hypothetical compound in Daniel Trachsel's 2013 review of the field after his successful synthesis of the
2C-AL
Pharmaceutical compound
may result in some degree of greater potency in comparison. Subsequently, Daniel Trachsel reported in his book Phenethylamine: von der Struktur zur Funktion
Alpha-D
Chemical compound
Shulgin's book PiHKAL (Phenethylamines I Have Known and Loved). Subsequently, Daniel Trachsel listed BOHB's dose as 30 mg or more orally in his book Phenethylamine:
BOH-2C-B
on 3 December 2022. Retrieved 3 December 2022. "Landtagsprotokoll vom 2. Mrz 2023 - Abänderung des Allgemeinen Bürgerlichen Gesetzbuches und des Partnerschaftsgesetzes
LGBTQ_rights_in_Liechtenstein
besides the preceding compounds have largely not been explored. However, Daniel Trachsel and colleagues named many additional desoxyscalines in their 2013
Desoxyscaline
Pharmaceutical compound
certain visual alterations. It was described in the scientific literature by Daniel Trachsel in 2013, who cited personal communication with P. Rausch in 2009
2C-B-AN
Fantasy travel document
machine-readable zone (MRZ) enabling it to be scanned by an optical reader. However, in place of a valid ISO 3166-1 alpha-3 code in the MRZ "issuer" and "nationality"
World_Passport
Naturally occurring psychedelic compound
reported to augment the effects of mescaline in animals. On the other hand, Daniel Trachsel has stated that mescaline is not metabolized by MAO, instead being
Mescaline
Psychoactive substance found in plants in the family Apocynaceae
Yippie Dana Beal co-wrote the 1997 book The Ibogaine Story. American author Daniel Pinchbeck wrote about his own experience of ibogaine in his book Breaking
Ibogaine
Pharmaceutical compound
with a propyl group connecting the amine and the β position. According to Daniel Trachsel and colleagues in 2013, the pharmacology of 3-phenylpiperidine
3-Phenylpiperidine
Chemical compound
unknown. This is in notable contrast to many other NBOMe drugs. However, Daniel Trachsel has reported that NBOMe-mescaline at an oral dose of 50 mg three
NBOMe-mescaline
Pharmaceutical compound
2-Methylmescaline was first described in the scientific literature by Daniel Trachsel and colleagues in 2013. The source of the information cited by
2-Methylmescaline
Pharmaceutical compound
and it was unknown whether it produces psychedelic effects. According to Daniel Trachsel however, 2C-CN was inactive at a dose of 10 mg orally, whereas
2C-CN
Substituted amphetamine designer drug
1989 but was never published at the time, and was finally disclosed in Daniel Trachsel's review of the field in 2013. It has a binding affinity (Ki) of
DOPF
Pharmaceutical compound
still needed. 3C-BOH was first described in the scientific literature by Daniel Trachsel and colleagues in 2013 via personal communication with another
3C-BOH
Pharmaceutical compound
scientific literature by at least 1999. DOTFE was evaluated in humans by Daniel Trachsel, with these reports published in 2012 and 2013. DOx (psychedelics)
DOTFE
Pharmaceutical compound
mescaline at doses of 40 to 120 mg orally, albeit with distinct effects. Daniel Trachsel has expressed great interest in desoxyscalines like desoxymescaline
Desoxybromoscaline
Psychedelic drug
phenethylamine family, with psychedelic effects. It was first synthesised by Daniel Trachsel and colleagues in 2006. It is active at a dosage of 25 mg orally
2C-V
Pharmaceutical compound
described. The drug was first described in the scientific literature by Daniel Trachsel in 2002. The pharmacology of fluoroproscaline was studied in greater
Fluoroproscaline
Chemical compound
doi:10.1021/jm8007097. ISSN 1520-4804. PMID 18834188. Holmberg, Pär; Sohn, Daniel; Leideborg, Robert; Caldirola, Patrizia; Zlatoidsky, Pavel; Hanson, Sverker;
3-Aminochroman
Pharmaceutical compound
reported to produce hallucinogenic effects in humans. Its dose was reported by Daniel Trachsel to be 80 mg or more orally and no duration was listed. In addition
2C-T-27
Pharmaceutical compound
a psychedelic drug of the phenethylamine and 2C families. According to Daniel Trachsel, 2C-O-22 produced potential threshold effects at a dose of 42 mg
2C-O-22
CHCl3, historical anaesthetic and common solvent
Organic Chemistry (Third edition corrected and much extended), 1852, page 177 Daniel Pereira Gardner, Medicinal Chemistry for the Use of Students and the Profession:
Chloroform
Pharmaceutical compound
interactions. MFEM was first described in the scientific literature by Daniel Trachsel by 2012. DOx (psychedelics) MEM § Derivatives Trachsel D, Lehmann
MFEM_(drug)
2165–2170. doi:10.1016/0024-3205(78)90567-2. PMID 672453. Usdin, Earl; Effron, Daniel H. (1972). "Aromatic Compounds: Phenethylamine Derivatives". Psychotropic
Phenylcyclopropylamine
Pharmaceutical compound
completed the chemical synthesis of 2C-T-22 and did not test it. Subsequently, Daniel Trachsel completed the synthesis of 2C-T-22 and defined its dose as greater
2C-T-22
Chemical compound
but their activity has not been tested separately. BMB was described by Daniel Trachsel in his 2013 book Phenethylamine: Von der Struktur zur Funktion
Β-Methyl-2C-B
Pharmaceutical compound
and 2C families related to 2C-E and 2C-TFM. It was first synthesised by Daniel Trachsel, and is reportedly a potent psychedelic with an active dose in
2C-TFE
Pharmaceutical compound
18 hours. Ψ-2C-DFMO was first described in the scientific literature by Daniel Trachsel in 2012. It is a controlled substance in Canada under phenethylamine
Ψ-2C-DFMO
Chemical compound
1471-4159.2008.05774.x. PMID 19012744. Schneider, C. S.; Weber, K. H.; Daniel, H.; Bechtel, W. D.; Boeke-Kuhn, K. (1984). "Synthesis and antidepressant
Tetrahydroisoquinoline
Chemical element with atomic number 30 (Zn)
smelting process by building the first horizontal retort smelter. Jean-Jacques Daniel Dony built a different kind of horizontal zinc smelter in Belgium that processed
Zinc
Central nervous system stimulant
exercise reduces withdrawal symptoms and relapse in abstinent smokers (Daniel et al., 2006; Prochaska et al., 2008), and one drug recovery program has
Amphetamine
Pharmaceutical compound
in the 1990s or 2000s. It was described in the scientific literature by Daniel Trachsel in 2013, who cited personal communication with Rausch as the source
2C-DB
Pharmaceutical compound
psychedelic of the phenethylamine, amphetamine, and DOx families. According to Daniel Trachsel, it produces hallucinogenic effects with a dose range of 2 to 6 mg
DOYN
Pharmaceutical compound
activity in animals. MMALM was first described in the scientific literature by Daniel Trachsel in 2013. Subsequently, it was characterized in more detail by a
MMALM
Psychedelic drug
it in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved) and Daniel Trachsel synthesized it in 2002, but neither of them reported its properties
3C-P
Psychedelic drug
synthetic step. Synthesis of 2C-T-16 was finally achieved by Daniel Trachsel some years later. Daniel Trachsel reported 2C-T-16 as showing similar psychedelic
2C-T-16
Pharmaceutical compound
receptor modulator of the phenethylamine and 2C families that was developed by Daniel Trachsel and David E. Nichols and colleagues. The drug's affinity (Ki) for
2C-Ph
Pharmaceutical compound
in the 1990s or 2000s. It was described in the scientific literature by Daniel Trachsel in 2013, who cited personal communication with Rausch as the source
DODB
Pharmaceutical compound
6-Dimethylmescaline was first described in the scientific literature by Daniel Trachsel and colleagues in 2013. The source of the information cited by
2,6-Dimethylmescaline
Amino acid and neurotransmitter
PMC 2193629. PMID 17202478. Xi, Zheng-Xiong; Baker, David A.; Shen, Hui; Carson, Daniel S.; Kalivas, Peter W. (2002). "Group II metabotropic glutamate receptors
Glutamic_acid
Proceedings, in Brown Dwarfs and Extrasolar Planets, R. Rebolo, E. L. Martin, and M.R.Z. Osorio (eds.), A.S.P. Conference Series 134, San Francisco, California
Methods of detecting exoplanets
Methods_of_detecting_exoplanets
Pharmaceutical compound
of the 3,4-methylenedioxy ring have been replaced with fluorine atoms. Daniel Trachsel tested DFMDMA in humans and found that it was inactive at doses
DFMDMA
Psychedelic drug
but was never made or tested by him, and was instead first synthesised by Daniel Trachsel some years later. It has a binding affinity of 75 nM at 5-HT2A
2C-T-28
Chemical compound
drug of the phenethylamine and 2C families. It was first synthesized by Daniel Trachsel and colleagues in 2006 and was subsequently described by them in
2C-CP
Psychoactive drug
produce amphetamine-like effects with no other details provided. However, Daniel Trachsel reported that 6-bromo-MDA was inactive at doses of up to 350 mg
2-Bromo-4,5-methylenedioxyamphetamine
2-Bromo-4,5-methylenedioxyamphetamine
Chemical compound
synthesised at that time. 2C-T-21.5 was ultimately synthesised and tested by Daniel Trachsel some years later. It has a binding affinity of 146 nM at 5-HT2A
2C-T-21.5
Pharmaceutical compound
but was never made or tested by him, and was instead first synthesised by Daniel Trachsel some years later. It has a binding affinity of 11nM at 5-HT2A and
2C-T-3
Pharmaceutical compound
3074–3084. doi:10.1021/jm9906062. PMID 10956215. US patent 20230285327, Daniel Trachsel; Matthias Emanuel Liechti & Felix Lustenberger, "Desoxyscaline
4-Bromo-3,5-dimethoxyamphetamine
4-Bromo-3,5-dimethoxyamphetamine
Pharmaceutical compound
Subsequently, MIPM was characterized in more detail by a group including Daniel Trachsel and Matthias Liechti in 2019. The compound's name is said to derive
MIPM
Pharmaceutical compound
in the scientific literature, as a theoretical compound of interest, by Daniel Trachsel in 2013. Various related theoretical compounds were also discussed
Diaza-2C-DFLY
Pharmaceutical compound
receptors and targets. It was first described in the scientific literature by Daniel Trachsel in 2012. Subsequently, its pharmacology was studied in greater
Metadifluoromescaline
Psychedelic drug
2C-TFM. The drug is the most potent known DOx psychedelic. According to Daniel Trachsel, DOTFM is active as a psychedelic in humans at doses of 0.3 to
DOTFM
Pharmaceutical compound
observed disorientation in their subjects, who also reported hallucinations. Daniel M. Perrine (2001). "Visions of the Night Western Medicine Meets Peyote 1887-1899"
Pellotine
Pharmaceutical compound
interactions. MDFEM was first described in the scientific literature by Daniel Trachsel by 2012. DOx (psychedelics) MEM § Derivatives Trachsel D, Lehmann
MDFEM
Pharmaceutical compound
activity in animals. MTFEM was first described in the scientific literature by Daniel Trachsel in 2012. Its psychoactive effects in humans were reported by Trachsel
MTFEM
Pharmaceutical compound
group has been replaced with a 4-(4-fluorobutylthio) group. According to Daniel Trachsel, 2C-T-30 was not clearly active at a dose of 6 mg plus 3 mg orally
2C-T-30
Pharmaceutical compound
5-HT2A receptor. It was first described in the scientific literature by Daniel Trachsel in 2012. The drug's pharmacology was studied in more detail in
Difluoromescaline
Pharmaceutical compound
activity in animals. MALM was first described in the scientific literature by Daniel Trachsel in 2013. Subsequently, it was characterized in more detail by a
MALM_(drug)
Family of phenethylamine psychedelics
doi:10.1007/s40263-025-01256-7. PMID 41546846. Gil-Martins, Eva; Barbosa, Daniel José; Borges, Fernanda; Remião, Fernando; Silva, Renata (June 2025). "Toxicodynamic
2C_(psychedelics)
Pharmaceutical compound
Substituted tetrahydroisoquinoline Peyophorine (N-ethylanhalonine) Anhalonine Daniel M. Perrine (2001). "Visions of the Night Western Medicine Meets Peyote 1887-1899"
Lophophorine
Pharmaceutical compound
uneventful tiredness without any noticed central effects of a sensory nature. Daniel M. Perrine (2001). "Visions of the Night Western Medicine Meets Peyote 1887-1899"
Anhalonine
Pharmaceutical compound
himself. Subsequently, 2C-EF was synthesized and tested by others such as Daniel Trachsel. 2C-EF is a controlled substance in Canada under phenethylamine
2C-EF
Pharmaceutical compound
Trifluoroescaline was first described in the scientific literature by Daniel Trachsel in 2002. Its pharmacology was studied in more detail in 2021. It
Trifluoroescaline
Pharmaceutical compound
published scientific literature. Correspondingly, the drug is not included in Daniel Trachsel's 2013 book Phenethylamine: von der Struktur zur Funktion. However
2CB-5-EtO
Chemical compound
Have Known and Loved), but he did not synthesize or test 3C-AL. Instead, Daniel Trachsel synthesized 3C-AL in 2002 and described its properties and effects
3C-AL
Chemical compound
Athreya, Arjun P.; Biernacka, Joanna M.; Bobo, William V.; Hall-Flavin, Daniel K.; Skime, Michelle K.; Zhu, Hongjie; Jenkins, Gregory D. (January 10, 2018)
Kynurenine
Psychedelic drug
formally tested in humans and its properties and effects are unknown. However, Daniel Trachsel has reported based on anonymous personal communication in 2009
TCB-2
Pharmaceutical compound
colleagues by 1998. Subsequently, it was described in greater detail by Daniel Trachsel and colleagues in 2013. The source of the information cited by
2-Iodomescaline
Pharmaceutical compound
described. Fluoroescaline was first described in the scientific literature by Daniel Trachsel in 2002. Its pharmacology was subsequently described in further
Fluoroescaline
Pharmaceutical compound
but was never tested by Shulgin. Subsequently, the drug was tested by Daniel Trachsel and colleagues, and was found to be active in a dose range of 50
4C-B
Pharmaceutical compound
itself. Tomscaline was first described in the scientific literature by Daniel Trachsel and colleagues in their 2013 book Phenethylamine: von der Struktur
Tomscaline
Disease pathology and physiology
blood. Those that are in CNS but not in blood suggest a diagnosis of MS. MRZ-Reaction: A polyspecific antiviral immune response against the viruses of
Pathophysiology of multiple sclerosis
Pathophysiology_of_multiple_sclerosis
Pharmaceutical compound
determined by David E. Nichols and colleagues, with subsequent disclosure by Daniel Trachsel and colleagues via personal communication in 2013. 2,6-Dichloromescaline
2,6-Dichloromescaline
DANIEL MRZ
DANIEL MRZ
Female
Italian
 Feminine form of Italian Daniele, DANIELA means "God is my judge." Compare with another form of Daniela.
Girl/Female
American, Australian, British, English, French, Greek, Hebrew
A Combination of Danielle and Janice; Feminine Variant of Daniel; God is Mu Judge
Female
Hebrew
Variant spelling of Hebrew Daniela, DANIELLA means "God is my judge."
Girl/Female
African, American, Assamese, Australian, British, Chinese, Christian, Danish, Dutch, English, French, German, Gujarati, Hawaiian, Hebrew, Indian, Jamaican, Sindhi, Swedish, Swiss
God is My Judge; Feminine of Daniel; Judged Only by God
Male
Hebrew
(×‘Ö¼Ö¸× Ö´×™Ö¼×ֵל) Hebrew name DANIYEL means "God is my judge." In the bible, this is the name of the hero of the Book of Daniel, who was cast into a den of lions but saved by God.
Girl/Female
American, Australian, Danish, French, German, Hebrew, Swiss
God is My Judge; Female Version of Daniel
Surname or Lastname
English, North German, Dutch, and Jewish (Ashkenazic)
English, North German, Dutch, and Jewish (Ashkenazic) : patronymic from the personal name Daniel.
Surname or Lastname
English
English : occupational name for a dancer or acrobat, from an agent derivative of Middle English, Old French dance ‘dance’ (see Dance).Translation of German Dänzer or Danser (see Danzer).
Male
English
 Anglicized form of Greek Daniēl (Hebrew Daniyel), DANIEL means "God is my judge." In the bible, this is the name of the hero of the Book of Daniel, who was cast into a den of lions but saved by God. Anglicized form of Scottish Gaelic Domhnall, meaning "world ruler."
Female
Hebrew
(×“Ö¼Ö¸× Ö´×™Ö¼×ֵלָה) Feminine form of Hebrew Daniyel, DANIELA means "God is my judge."
Female
Slavic
Variant spelling of Slavic Danica, DANIKA means "morning star."
Girl/Female
American, Australian, British, Chinese, Christian, Danish, English, French, German, Hebrew, Italian, Jewish, Swedish
God is My Judge; Female Version of Daniel; Judge
Boy/Male
American, British, English, French
Open; Variant of Darrel Open
Male
Italian
Italian form of Hebrew Daniyel, DANIELE means "God is my judge."
Girl/Female
American, Australian
Female Version of Daniel
Surname or Lastname
English, French, Spanish, Portuguese, German, Polish, Czech, Slovak, Hungarian (Dániel), Romanian, and Jewish
English, French, Spanish, Portuguese, German, Polish, Czech, Slovak, Hungarian (Dániel), Romanian, and Jewish : from the Hebrew personal name Daniel ‘God is my judge’, borne by a major prophet in the Bible. The major factor influencing the popularity of the personal name (and hence the frequency of the surname) was undoubtedly the dramatic story in the Book of Daniel, recounting the prophet’s steadfast adherence to his religious faith in spite of pressure and persecution from the Mesopotamian kings in whose court he served: Nebuchadnezzar and Belshazzar (at whose feast Daniel interpreted the mysterious message of doom that appeared on the wall, being thrown to the lions for his pains). The name was also borne by a 2nd-century Christian martyr and by a 9th-century hermit, the legend of whose life was popular among Christians during the Middle Ages; these had a minor additional influence on the adoption of the Christian name. Among Orthodox Christians in Eastern Europe the name was also popular as being that of a 4th-century Persian martyr, who was venerated in the Orthodox Church.Irish : reduced form of McDaniel, which is actually a variant of McDonnell, from the Gaelic form of Irish Donal (equivalent to Scottish Donald), erroneously associated with the Biblical personal name Daniel. See also O’Donnell.Peter Daniel was one of the pioneer settlers in the 17th century in Stafford County, VA, where he was a justice of the peace. His grandson, Peter Vivian Daniel, was a U.S. Supreme Court justice from 1841 to his death in Richmond, VA, in 1860.
Girl/Female
Christian & English(British/American/Australian)
Feminine of Daniel
Female
French
French feminine form of Hebrew Daniyel (English Daniel), DANIELLE means "God is my judge."Â
Female
English
French feminine form of Hebrew Daniyel, DANIELLE means "God is my judge."Â
Surname or Lastname
English
English : variant spelling of Daniel.
DANIEL MRZ
DANIEL MRZ
Girl/Female
Arabic, Muslim
The Most Beautiful Hur with Beautiful Eyes
Boy/Male
Hindu, Indian
Divine
Girl/Female
Gujarati, Hindu, Indian
A Person who Greater than Anyone; Perfection
Boy/Male
Indian, Sanskrit
Divine State; Divine Feeling
Boy/Male
Hindu, Indian
Light of the Teacher
Girl/Female
Indian
Unique
Girl/Female
Hindu, Indian
Increase
Girl/Female
Bengali, Indian
Fulfillment of Wish
Biblical
saying; speaking; a lambtalkative; prominent;
Girl/Female
Tamil
Boat
DANIEL MRZ
DANIEL MRZ
DANIEL MRZ
DANIEL MRZ
DANIEL MRZ
n.
A refusal to acknowledge; disclaimer of connection with; disavowal; -- the contrary of confession; as, the denial of a fault charged on one; a denial of God.
n.
A Moorish dance, usually performed by a single dancer, who accompanies the dance with castanets.
v. t.
To form in or with panels; as, to panel a wainscot.
a.
Belonging to the Danes, or to their language or country.
v. t.
To cause to dance, or move nimbly or merrily about, or up and down; to dandle.
n.
One of a breed of small terriers; -- called also Dandie Dinmont.
v. t.
To follow like a spaniel.
n.
One who dances or who practices dancing.
v. t.
To cause to dangle; to swing, as something suspended loosely; as, to dangle the feet.
n.
One who denies; as, a denier of a fact, or of the faith, or of Christ.
n.
The language of the Danes.
n.
A young person, either male or female, of noble or gentle extraction; as, Damsel Pepin; Damsel Richard, Prince of Wales.
n.
A board having its edges inserted in the groove of a surrounding frame; as, the panel of a door.
imp. & p. p.
of Dance
n.
A Hebrew prophet distinguished for sagacity and ripeness of judgment in youth; hence, a sagacious and upright judge.
n.
The denial of one's self; forbearing to gratify one's own desires; self-sacrifice.